Supplementary Figure S4 from Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 Signaling

Josephs, Debra H.; Bax, Heather J.; Dodev, Tihomir; Georgouli, Mirella; Nakamura, Mano; Pellizzari, Giulia; Saul, Louise; Karagiannis, Panagiotis; Cheung, Anthony; Herraiz, Cecilia; Ilieva, Kristina M.; Correa, Isabel; Fittall, Matthew; Crescioli, Silvia; Gazinska, Patrycja; Woodman, Natalie; Mele, Silvia; Chiaruttini, Giulia; Gilbert, Amy E.; Koers, Alexander; Bracher, Marguerite; Selkirk, Christopher; Lentfer, Heike; Barton, Claire; Lever, Elliott; Muirhead, Gareth; Tsoka, Sophia; Canevari, Silvana; Figini, Mariangela; Montes, Ana; Downes, Noel; Dombrowicz, David; Corrigan, Christopher J.; Beavil, Andrew J.; Nestle, Frank O.; Jones, Paul S.; Gould, Hannah J.; Sanz-Moreno, Victoria; Blower, Philip J.; Spicer, James F.; Karagiannis, Sophia N.

doi:10.1158/0008-5472.22416014.v1

00085472can161829-sup-168591_2_supp_3778603_ww1m0y.pdf (105.93 kB)

Supplementary Figure S4 from Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 Signaling

journal contribution

posted on 2023-03-31, 01:03 authored by Debra H. Josephs, Heather J. Bax, Tihomir Dodev, Mirella Georgouli, Mano Nakamura, Giulia Pellizzari, Louise Saul, Panagiotis Karagiannis, Anthony Cheung, Cecilia Herraiz, Kristina M. Ilieva, Isabel Correa, Matthew Fittall, Silvia Crescioli, Patrycja Gazinska, Natalie Woodman, Silvia Mele, Giulia Chiaruttini, Amy E. Gilbert, Alexander Koers, Marguerite Bracher, Christopher Selkirk, Heike Lentfer, Claire Barton, Elliott Lever, Gareth Muirhead, Sophia Tsoka, Silvana Canevari, Mariangela Figini, Ana Montes, Noel Downes, David Dombrowicz, Christopher J. Corrigan, Andrew J. Beavil, Frank O. Nestle, Paul S. Jones, Hannah J. Gould, Victoria Sanz-Moreno, Philip J. Blower, James F. Spicer, Sophia N. Karagiannis

Evaluation of FRalpha expression by tumor cell lines

Funding

Cancer Research UK

Academy of Medical Sciences

Medical Research Council

Cancer Medicine Centre

Royal Society

History

ARTICLE ABSTRACT

IgE antibodies are key mediators of antiparasitic immune responses, but their potential for cancer treatment via antibody-dependent cell-mediated cytotoxicity (ADCC) has been little studied. Recently, tumor antigen–specific IgEs were reported to restrict cancer cell growth by engaging high-affinity Fc receptors on monocytes and macrophages; however, the underlying therapeutic mechanisms were undefined and in vivo proof of concept was limited. Here, an immunocompetent rat model was designed to recapitulate the human IgE-Fcϵ receptor system for cancer studies. We also generated rat IgE and IgG mAbs specific for the folate receptor (FRα), which is expressed widely on human ovarian tumors, along with a syngeneic rat tumor model expressing human FRα. Compared with IgG, anti-FRα IgE reduced lung metastases. This effect was associated with increased intratumoral infiltration by TNFα+ and CD80+ macrophages plus elevated TNFα and the macrophage chemoattractant MCP-1 in lung bronchoalveolar lavage fluid. Increased levels of TNFα and MCP-1 correlated with IgE-mediated tumor cytotoxicity by human monocytes and with longer patient survival in clinical specimens of ovarian cancer. Monocytes responded to IgE but not IgG exposure by upregulating TNFα, which in turn induced MCP-1 production by monocytes and tumor cells to promote a monocyte chemotactic response. Conversely, blocking TNFα receptor signaling abrogated induction of MCP-1, implicating it in the antitumor effects of IgE. Overall, these findings show how antitumor IgE reprograms monocytes and macrophages in the tumor microenvironment, encouraging the clinical use of IgE antibody technology to attack cancer beyond the present exclusive reliance on IgG. Cancer Res; 77(5); 1127–41. ©2017 AACR.